Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas

THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL ANY SHARES OR AMERICAN DEPOSITARY SHARES, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH, OR TO ANY PERSON TO OR FROM WHOM, SUCH OFFER OR SOLICITATION PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES.

BioStock: Saniona aiming for new clinical data and first market approval

In its recently published interim report, Saniona’s CEO Thomas Feldthus highlights the external interest in one of the clinical candidates and two of the preclinical candidates, while reiterating the target of delivering clinical updates for SAN711 and SAN2355 before year-end. The company is also eyeing a possible first market approval of tesofensine, targeting the obesity market.– We are awaiting the final decision for approval of tesofensine for obesity in Mexico. If successful, Saniona will be entitled to an upfront payment and double-digit royalties on product sales.Read the article

Form 8.3 - Britvic Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +------------------------------------------------+----------------------------+|(a) Full name of discloser: |Magnetar Capital Partners LP|+------------------------------------------------+----------------------------+|(b) Owner or controller of interests and short |  ||positions disclosed, if different from 1(a):

Notice to extraordinary general meeting in Wyld Networks AB

N.B.   This notice has been prepared in both Swedish and English language versions. In the event of any discrepancies between the versions, the Swedish version shall prevail. Shareholders of Wyld Networks AB are hereby invited to an extraordinary general meeting on 2 October 2024 14:00 CEST at Advokatfirman Schjødt, Hamngatan 27, in Stockholm. Right to participate Shareholders who wish to participate in the meeting must be recorded in the share register maintained by Euroclear Sweden AB on 24 September 2024. Shareholders who intend to participate in the extraordinary general

SOFTSWISS To Arrange a Track Day with Rubens Barrichello During SBC Summit Lisbon

SOFTSWISS, a global tech expert with over 15 years of experience providing innovative iGaming solutions, announces a special track day event at the legendary Estoril Circuit in Portugal led by the company’s Non-Executive Director in Latin America, Rubens Barrichello.The track day is an exclusive event to be organised for SOFTSWISS’ VIP business partners. Scheduled during the SBC Summit Lisbon , it will offer networking opportunities alongside an unforgettable real-life driving

"We Dig Where We Stand" – Environmental Sheds Get New Life Through Stockholmshem and Bruske Måleri

The housing company Stockholmshem annually brings in young people during the summer to carry out projects aimed at increasing comfort and safety in their tenants' communities. This year, Nadine Hanna, area developer for Hässelby Gård, Hässelby Strand and Rinkeby at Stockholmshem, chose to focus on repainting the environmental sheds on the properties to improve waste management for tenants. To ensure the project was as effective as possible, painting expertise was needed to guide the young workers. Bruske Måleri, with its extensive experience and commitment, immediately agreed to contribute

Launch of Zeqmelit® Initiated – Now Available at Pharmacies

AcuCort has previously announced that the market launch of Zeqmelit® would begin in early September. In line with this plan, Zeqmelit® is available at Swedish pharmacies starting today, Monday, September 2nd. The product will soon also be available at pharmacies in Norway and Finland.– The launch is proceeding exactly as planned, and we have thus achieved yet another important milestone. Physicians can prescribe Zeqmelit®, and the product is now available at Swedish pharmacies. It will soon also be available at pharmacies in Norway and Finland, says AcuCort's CEO, Jonas Jönmark.  For

Teleste Introduces Teleste Hub: Revolutionizing Content Management for the Public Transportation Market

The new software provides public transport operators with a powerful tool to drive continuous improvement, boost operational efficiency, and unlock new revenue streams.Turku, Finland – 2 September 2024 – Teleste, a leading provider of innovative technology solutions, is proud to announce the launch of its new central software for content management, Teleste Hub. Specifically tailored for the public transportation industry, Teleste Hub is set to redefine how transit operators manage, distribute, and display content across their networks. Developed in partnership with ITESMEDIA, a trusted

Ethical, Social Questions about Breastfeeding Interventions Now Easier to Assess

A new framework for assessing whether breastfeeding interventions are ethical and socially appropriate is now available. Built by ethics experts from the University of Zurich, it can help answer important questions, like: How can an infant’s rights be protected? How can a mother’s dignity be safeguarded?Joint media release: University of Zurich and Family Larsson-Rosenquist Foundation Zurich and Frauenfeld, Switzerland, 2 September 2024 – The University of Zurich (UZH) and the Family Larsson-Rosenquist Foundation (FLRF) have launched a free framework for assessing whether breastfeeding

Rear Admiral Juha Vauhkonen Joins Summa Defence Ltd's Executive Board

Press Release    September 2, 2024, CET 13:00   Rear Admiral Juha Vauhkonen Joins Summa Defence Ltd's Executive Board   Summa Defence Ltd strengthens its Executive Board by appointing former Chief of Intelligence at the Defence Command, Rear Admiral Juha Vauhkonen, as the company's Director of Defence and Security Affairs, effective from September 2, 2024. Vauhkonen will be responsible for the strategic management and development of the company's defence and security affairs, creating value and competitiveness for the company.   Vauhkonen has an extremely broad industry

Summer 2025: Swedish Opera på Skäret to stage Turandot

It has been eight years since Opera på Skäret last produced an opera by Giacomo Puccini. Now, it's finally time again. In the summer of 2025, the opera Turandot will be staged in the large timber warehouse by the shores of Lake Ljusnaren.After this past summer’s success with Vincenzo Bellini’s opera Norma, the exciting work of planning and recruiting the production team and soloists now begins. It has already been confirmed that the fantastic Swedish Chamber Orchestra will take its place in the orchestra pit at Opera på Skäret next summer. The production team will be announced later this

TOMRA: Digital participation at Capital Markets Day on Thursday, 5 September

TOMRA will host a Capital Markets Day on Thursday 5 September at 08:00 CEST in Alicante, Spain. The presentations can be viewed via webcast on:https://www.tomra.com/en/investor-relations/capital-markets-day Viewers who would like to actively participate in the Q&A session are welcome to pre-register for the TEAMS webinar:https://events.teams.microsoft.com/event/1899f22e-adbb-4c14-bed6-32293605d768@4308d118-edd1-4300-8a37-cfeba8ad5898 Agenda (all times in CEST) 07:00 | Publication of presentation08:00 | Welcome08:20 | Recycling, Collection and Food09:05 | Break09:30 |

Spinomenal Scores New Deal With 711

Spinomenal, the leading iGaming content provider, has scored a new deal with leading Dutch operator, 711.nl.The partnership sees a selection of Spinomenal’s top performing games joining the 711.nl casino lobby, including Queen of Ice, Book of Rebirth, Athena’s Glory, and Fairytale Beauties. 711.nl will integrate these titles via the Bragg Gaming Group platform. Lior Shvartz, Co-CEO for Spinomenal commented: “Joining forces with 711.nl, one of the Netherlands’ leading operators, is a big moment for the business. The Netherlands is an important market within our growth strategy and we

Composition of Elisa's Shareholders' Nomination Board

ELISA CORPORATION STOCK EXCHANGE RELEASE 2 SEPTEMBER 2024 AT 1:00 PMComposition of Elisa's Shareholders' Nomination Board is following: · Mr Pauli Anttila, Investment Director, nominated by Solidium Oy · Mr Jouko Pölönen, President and CEO, nominated by Ilmarinen Mutual Pension Insurance Company · Mr Markus Aho, Chief Investment Officer, nominated by Varma Mutual Pension Insurance Company · Ms Jonna Ryhänen, Chief Investment Officer, Deputy CEO, nominated by Elo Mutual Pension Insurance Company · Mr Anssi Vanjoki, Chair of the Board of Elisa  The Nomination Board shall

Vattenfall to pause offshore wind project Swedish Kriegers Flak

Vattenfall has decided to pause the development of the offshore wind power project Swedish Kriegers Flak until further notice, due to unviable investment prerequisites in Sweden.Swedish Kriegers Flak, located about 30 km south of Trelleborg, is Sweden's most mature offshore wind power project. The wind farm is estimated to generate 2.7 TWh of fossil-free electricity per year. The investment prerequisites for offshore wind in Sweden are currently not viable and Vattenfall has therefore decided to pause all further development of the project. The wind farm was planned for production start

Immunovia publishes preliminary outcome in rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.                                                                                                  LUND (SWEDEN) – Immunovia AB (publ) (“Immunovia” or the “Company”) today announces the preliminary outcome of the rights

CBCT for the GP – how to become (still) more successful at the dentistry you already provide

CBCT technology has brought tremendous advantages to dental diagnostics and treatment planning, especially in endodontics, implant planning, and oral surgery. But what about 3D for general dentistry? Some might argue that 2D imaging has been used successfully for years and there is no reason to change. Yet, a growing number of GPs are incorporating CBCT imaging into their routine diagnostic workflows. Are these GPs trailblazers? Do they perform more advanced dentistry? Do they know something you don’t? Or maybe they have simply discovered that CBCT imaging makes them better at the

Double certification of Absolicon's quality and environmental management system through ISO 9001 and ISO 14001

Absolicon announces its certification in two significant ISO standards: ISO 9001 for Quality Management and ISO 14001 for Environmental Management.Achieving these certifications is a milestone for Absolicon, demonstrating the company's maturity and capability to deliver with both high quality and environmental responsibility. The International Organization for Standardization (ISO) certification is globally recognized and establishes credibility and trust among consumers, clients, and business partners. ISO 9001: Quality Management The ISO 9001 certification for Quality Management

Acquisitions of own shares in Evolution AB (publ)

Evolution AB (publ) (“Evolution”) has, during the period 26 August - 30 August acquired a total of 519,621 own shares within the framework of the repurchase programme introduced by the board of directors to improve the capital structure of Evolution by reducing the capital, and thereby creating added shareholder value.The repurchase programme, which Evolution announced on 18 July 2024, is being implemented in accordance with the EU Market Abuse Regulation No 596/2014 (“MAR”) and Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”). During the period 26 August - 30

New paper using Attana technology for development of therapeutic antibodies against cancer

We are very happy that Attana technology has more or less from the start been involved in taking a malaria parasite protein towards a generic cancer treatment!   The latest work, published in Nature Communications  describes that translation into clinical trials turned out to be complicate e.g. by complex manufacturing and expensive scale-up processes of the malaria protein. Converting it into antibodies turned out to be the trick.   Antibody manufacturing is significantly less complicated than protein manufacturing. Attana

Buyback of Class B shares in Essity during week 35, 2024

Between August 26, 2024, and August 30 2024, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.The share purchase is part of the SEK 3bn buyback program announced by Essity on June 17, 2024. The buyback program will extend from June 17, 2024, until the 2025 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission’s Delegated Regulation 2016/1052 (Safe Harbour Regulation). The share repurchase is

CANNORDIC India Ltd., a CS MEDICA Subsidiary, Signs Letter of Intent with the Pharmaceutical Company Zuventus Healthcare to Launch CANNASEN® in India

The Partnership Projects Up to €15 Million Revenue from Innovative CBD-infused Medical Devices by Year Three Post-Registration.CANNORDIC India Ltd., under the umbrella of CS MEDICA Group, has signed a Letter of Intent (LOI) with Zuventus Healthcare Ltd., a premier pharmaceutical company in India. This agreement marks the initial engagement towards establishing a preferred partnership for distributing and marketing the CANNASEN® brand within the medical device category across India. The partnership will focus on addressing autoimmune diseases and stress-related disorders. The

The exercise period for Diamyd Medical's warrants of series TO 3 begins today

In 2023, Diamyd Medical AB (publ) (”Diamyd Medical” or the ”Company”) issued a total of 9,165,682 warrants of series TO 3 as part of a rights issue of units. The exercise period for the warrants will begin on September 2, 2024, and will continue until September 30, 2024. Two (2) warrants of either series TO 3 A or TO 3 B entitle the holder to subscribe for one (1) new share of the corresponding series, in the Company at a subscription price of SEK 11.00 per share. Chairman of the Board and major shareholder Anders Essen-Möller and CEO Ulf Hannelius have in advance announced their intention to

A few seats open – Last call for MilDef's Capital Markets Day September 17, 2024

Representatives from MilDef's Group Management, headed by President and CEO Daniel Ljunggren, will present MilDef's development and strategies for continued growth. Sign up is made at link below, no later than September 5.The Capital Markets Day will be held at At Six, Brunkebergstorg 6 in Stockholm for shareholders, analysts and media. The program starts at 9.00 and ends with lunch at 12.30. The agenda includes: · Strategy and company presentation, Daniel Ljunggren, President/CEO · Presentation of offering and product strategy, Fredrik Persson, CTO/Deputy CEO · Market

There are no items matching the current filter
There are no more items matching the current filter
Back to top